201 related articles for article (PubMed ID: 31729414)
1. CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.
Lee K; Jeong HO; Lee S; Jeong WK
Sci Rep; 2019 Nov; 9(1):16927. PubMed ID: 31729414
[TBL] [Abstract][Full Text] [Related]
2. Machine learning random forest for predicting oncosomatic variant NGS analysis.
Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
[TBL] [Abstract][Full Text] [Related]
3. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
4. A deep learning-based multi-model ensemble method for cancer prediction.
Xiao Y; Wu J; Lin Z; Zhao X
Comput Methods Programs Biomed; 2018 Jan; 153():1-9. PubMed ID: 29157442
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Predictability of Cancer Types from 536 Somatic Mutations: A New Dataset.
Dehkharghanian T; Rahnamayan S; Tizhoosh HR
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5308-5311. PubMed ID: 33019182
[TBL] [Abstract][Full Text] [Related]
6. Reviewing ensemble classification methods in breast cancer.
Hosni M; Abnane I; Idri A; Carrillo de Gea JM; Fernández Alemán JL
Comput Methods Programs Biomed; 2019 Aug; 177():89-112. PubMed ID: 31319964
[TBL] [Abstract][Full Text] [Related]
7. NeoMutate: an ensemble machine learning framework for the prediction of somatic mutations in cancer.
Anzar I; Sverchkova A; Stratford R; Clancy T
BMC Med Genomics; 2019 May; 12(1):63. PubMed ID: 31096972
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer somatic mutation embedding using autoencoders.
Palazzo M; Beauseroy P; Yankilevich P
BMC Bioinformatics; 2019 Dec; 20(1):655. PubMed ID: 31829157
[TBL] [Abstract][Full Text] [Related]
9. Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations.
Agajanian S; Oluyemi O; Verkhivker GM
Front Mol Biosci; 2019; 6():44. PubMed ID: 31245384
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
Arango NP; Brusco L; Mills Shaw KR; Chen K; Eterovic AK; Holla V; Johnson A; Litzenburger B; Khotskaya YB; Sanchez N; Bailey A; Zheng X; Horombe C; Kopetz S; Farhangfar CJ; Routbort M; Broaddus R; Bernstam EV; Mendelsohn J; Mills GB; Meric-Bernstam F
Oncotarget; 2017 Jun; 8(26):41806-41814. PubMed ID: 28415679
[TBL] [Abstract][Full Text] [Related]
11. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
[TBL] [Abstract][Full Text] [Related]
12. Deep convolutional neural networks for accurate somatic mutation detection.
Sahraeian SME; Liu R; Lau B; Podesta K; Mohiyuddin M; Lam HYK
Nat Commun; 2019 Mar; 10(1):1041. PubMed ID: 30833567
[TBL] [Abstract][Full Text] [Related]
13. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Vural S; Wang X; Guda C
BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
[TBL] [Abstract][Full Text] [Related]
14. Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential.
Nath A; Sahu GK
J Theor Biol; 2019 Oct; 479():37-47. PubMed ID: 31310757
[TBL] [Abstract][Full Text] [Related]
15. SomaticSeq: An Ensemble and Machine Learning Method to Detect Somatic Mutations.
Fang LT
Methods Mol Biol; 2020; 2120():47-70. PubMed ID: 32124311
[TBL] [Abstract][Full Text] [Related]
16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
17. Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction.
Chen ML; Doddi A; Royer J; Freschi L; Schito M; Ezewudo M; Kohane IS; Beam A; Farhat M
EBioMedicine; 2019 May; 43():356-369. PubMed ID: 31047860
[TBL] [Abstract][Full Text] [Related]
18. Optimisation of cancer classification by machine learning generates an enriched list of candidate drug targets and biomarkers.
Ramroach S; Joshi A; John M
Mol Omics; 2020 Apr; 16(2):113-125. PubMed ID: 32095794
[TBL] [Abstract][Full Text] [Related]
19. Deep learning of mutation-gene-drug relations from the literature.
Lee K; Kim B; Choi Y; Kim S; Shin W; Lee S; Park S; Kim S; Tan AC; Kang J
BMC Bioinformatics; 2018 Jan; 19(1):21. PubMed ID: 29368597
[TBL] [Abstract][Full Text] [Related]
20. Correlation-Based Ensemble Feature Selection Using Bioinspired Algorithms and Classification Using Backpropagation Neural Network.
Elgin Christo VR; Khanna Nehemiah H; Minu B; Kannan A
Comput Math Methods Med; 2019; 2019():7398307. PubMed ID: 31662787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
